Cannabidiol (CBD) as a treatment of acute and chronic back pain: A case series and literature review

J Opioid Manag. 2020 May/Jun;16(3):215-218. doi: 10.5055/jom.2020.0570.

Abstract

Objective: Two patient case reports are presented describing the use of cannabidiol (CBD) for the symptomatic relief of a lumbar compression fracture and in the mitigation of thoracic discomfort and dysesthesia secondary to a surgically resected meningioma.

Discussion: CBD appears to have antisnociceptive and anti-inflammatory effects on opioid-naive patients with neuro-pathic and radicular pain. Of note, the patients in this case series used the same CBD cream: Baskin Essentials Body Wellness Cream (400 mg CBD per two oz.) Conclusion: Hemp-derived CBD in a transdermal cream provided significant symptom and pain relief for the patients described in this case series. Based on these results, we believe further investigation is warranted to see if CBD-containing products should have a more prominent role in the treatment of acute and chronic pain.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Analgesics, Opioid
  • Back Pain* / drug therapy
  • Cannabidiol* / therapeutic use
  • Cannabis*
  • Chronic Pain* / drug therapy
  • Humans

Substances

  • Analgesics, Opioid
  • Cannabidiol